Our Animal Nutrition & Health (ANH) Business Unit is a global innovation leader. It helps customers deliver healthy animal protein efficiently and sustainably while harnessing the power of data to make animal farming practices more sustainable, productive, and transparent.
In February 2024, we announced our intention to separate this business from the company, having concluded that its full potential could best be realized under a different ownership structure. In line with our new strategy, we repositioned the company, with its remaining three Business Units – Perfumery & Beauty, Taste, Texture & Health, and Health, Nutrition & Care – to focus exclusively on nutrition, health, and beauty.
ANH is a global provider of science-based animal nutrition and health solutions. The business offers products ranging from vitamins and premixes to feed additives that improve animal health, performance, feed efficiency, and sustainability across livestock production. Its solutions help producers deliver high-quality animal protein while reducing environmental impact.
The total ANH business represented approximately €3.5 billion of dsm-firmenich’s annual net sales and around €0.5 billion of the company’s total Adjusted EBITDA in 2025.
The divestment
Following the announcement, the divestment of our world-leading Animal Nutrition & Health business occurred in two stages.
In the first stage, completed on June 2, 2025, we sold our 50% stake in the Feed Enzymes Alliance to our partner Novonesis, a global leader in biosolutions, for €1.5 billion, receiving approximately €1.4 billion net in cash, after transaction costs.
In the second stage, announced on February 9, 2026, we agreed to sell our remaining ANH business to CVC Capital Partners for an enterprise value of about €2.2 billion. This includes an earnout of up to €500 million.
For ANH, this marks the beginning of a new chapter.
ANH will be split into two new standalone companies, both based in Kaiseraugst, Switzerland: the “Solutions Company,” including Performance Solutions, Premix, and Precision Services, and the “Essential Products Company,” including Vitamins, Carotenoids and Aroma Ingredients (jointly referred to as the “ANH Companies”).
These companies will continue to work closely together, especially with regard to the vitamin supply in the animal nutrition and health value chain.
dsm-firmenich will retain a 20% equity stake in each of the divested ANH Companies, in partnership with CVC, who will own the remaining 80%.
dsm-firmenich will also enter into a long-term vitamins supply agreement with the Essential Products Company to ensure continuity and supply security for human and pet food applications.
The transaction is expected to be completed at the end of 2026 and is subject to conditions including regulatory approvals, the finalization of all required employee consultation processes, and the creation and separation of a standalone Essential Products Company and standalone Solutions Company by dsm-firmenich.
We transferred our Bovaer® business to our Taste, Texture & Health Business Unit. Our Veramaris® business, the 50/50 joint-venture for algae-based Omega-3, is transferred into our Health, Nutrition & Care Business Unit.